Annual Drug Patent Expirations for WYNZORA
Wynzora is a drug marketed by MC2 and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has eighteen patent family members in fourteen countries.
The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. One supplier is listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com